Factor interaction analysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer.
about
The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology AdvancementsCharacterization of DNA Methylation in Circulating Tumor CellsA New Combinatorial Optimization Approach for Integrated Feature Selection Using Different Datasets: A Prostate Cancer Transcriptomic StudyInhibition of tumor cell motility by the interferon-inducible GTPase MxADecreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancerChanges in cortical cytoskeletal and extracellular matrix gene expression in prostate cancer are related to oncogenic ERG deregulation.Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers.Decreased expression of GRIM-19 by DNA hypermethylation promotes aerobic glycolysis and cell proliferation in head and neck squamous cell carcinoma.TLR3 engagement induces IRF-3-dependent apoptosis in androgen-sensitive prostate cancer cells and inhibits tumour growth in vivo.Toll-like receptors in prostate infection and cancer between bench and bedsideAndrogen receptor co-activators in the regulation of cellular events in prostate cancer.Hypomethylation of repeated DNA sequences in cancer.Tumor suppressor role of protein 4.1B/DAL-1.Epigenetic silencing of CRABP2 and MX1 in head and neck tumors.Interferon inducible antiviral MxA is inversely associated with prostate cancer and regulates cell cycle, invasion and Docetaxel induced apoptosis.Deregulation of an imprinted gene network in prostate cancer.ID4 is frequently downregulated and partially hypermethylated in prostate cancer.DKC1 overexpression associated with prostate cancer progression.Differential role of gene hypermethylation in adenocarcinomas, squamous cell carcinomas and cervical intraepithelial lesions of the uterine cervix.DNA Methylation and the HOXC6 Paradox in Prostate Cancer.
P2860
Q26750672-3A792A47-6AD2-4973-99FA-7FC426FB3F68Q26778427-07039D32-A2B9-44BE-9F57-3CC3009A1933Q28647934-78888F4B-0CB4-4AAC-8AA7-699C50082CF4Q30487769-205C6CC1-CCF3-4435-AF58-6363279E4AF4Q33298583-EBBFCA80-23D1-4A12-A8BB-5EAA27FCD7F5Q33699391-2B62BBD1-834F-4489-A9E0-CD11170A85DAQ34009859-E8D4A5E2-B096-491A-8F1D-7E052F8F80A1Q35238408-964962B2-3824-429E-A2A0-840D41933F81Q35531400-3983919F-CF8E-4A78-8279-0F2A31F37A21Q37295411-478675A3-F64C-47D5-8E7E-B854D67C63BDQ37959244-B9BB5E4C-444E-4478-8679-8F7601508E96Q37961724-CE1EE2FF-80D0-4C2F-83FC-39439389AD1FQ38245653-D443423F-2D1A-4BD3-9201-60FBB53D281CQ38347884-D4AA3F64-6ABD-4222-A1C4-8576C5EC33D5Q38946730-85614F85-79B6-4827-A68B-1C34DFA70AE0Q39025282-D2B4FC2E-75A5-48B6-BE1C-F01FC945FA13Q39481269-39BCD54B-E357-4B40-9BC3-EDDE3F52CEFAQ39799327-7E2287E0-93CC-4CF2-8829-D09071ED1852Q41083940-E2DECD1B-4B82-48AA-95D6-D4405244A78CQ42585509-980CAA1C-6869-4D0E-9906-441810567E84
P2860
Factor interaction analysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Factor interaction analysis fo ...... al changes in prostate cancer.
@en
type
label
Factor interaction analysis fo ...... al changes in prostate cancer.
@en
prefLabel
Factor interaction analysis fo ...... al changes in prostate cancer.
@en
P2093
P2860
P50
P356
P1433
P1476
Factor interaction analysis fo ...... al changes in prostate cancer.
@en
P2093
Adrian Alexa
Agnes Wlazlinski
Andrea R Florl
Bernd Wullich
Christiane Hader
Masanori Yamanaka
Michèle J Hoffmann
Mirko Müller
Rainer Engers
Sandy Fritzsche
P2860
P2888
P356
10.1186/1476-4598-6-14
P577
2007-02-05T00:00:00Z
P5875
P6179
1008985454